Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.
作者信息
Green Robert C, Lupski James R, Biesecker Leslie G
机构信息
Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
出版信息
JAMA. 2013 Jul 24;310(4):365-6. doi: 10.1001/jama.2013.41703.
Abstract
摘要
相似文献
1
Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.向开单临床医生报告基因组测序结果：虽属偶然，但并非罕见。
JAMA. 2013 Jul 24;310(4):365-6. doi: 10.1001/jama.2013.41703.
2
Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.所有基因组测序中的强制扩展搜索：“偶然发现”、患者自主权与共同决策
JAMA. 2013 Jul 24;310(4):367-8. doi: 10.1001/jama.2013.41700.
3
Return of secondary genomic findings vs patient autonomy: implications for medical care.二次基因组结果的反馈与患者自主权：对医疗护理的影响
JAMA. 2013 Jul 24;310(4):369-70. doi: 10.1001/jama.2013.41709.
4
Genomic test validation for incidental findings.偶然发现的基因组检测验证
Clin Chem. 2014 Feb;60(2):292-3. doi: 10.1373/clinchem.2013.210609. Epub 2013 Jul 1.
5
Point-counterpoint. Ethics and genomic incidental findings.针锋相对。伦理学与基因组偶然发现
Science. 2013 May 31;340(6136):1047-8. doi: 10.1126/science.1240156. Epub 2013 May 16.
6
Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.临床基因组测序中偶然发现结果反馈的社会偏好：一项离散选择实验
CMAJ. 2015 Apr 7;187(6):E190-E197. doi: 10.1503/cmaj.140697. Epub 2015 Mar 9.
7
Revealing the incidentalome when targeting the tumor genome.靶向肿瘤基因组时揭示偶发瘤
JAMA. 2013 Aug 28;310(8):795-6. doi: 10.1001/jama.2013.276573.
8
Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.二级变异和偶然发现披露讨论中临床遗传学家的伦理路标
Med Health Care Philos. 2015 Aug;18(3):361-70. doi: 10.1007/s11019-014-9611-8.
9
To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.是否告知？遗传学背景下偶然发现的伦理思考系统综述。
Eur J Hum Genet. 2013 Mar;21(3):248-55. doi: 10.1038/ejhg.2012.130. Epub 2012 Jun 27.
10
Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines.未成年人成年后发病疾病的预测性基因检测：对支持和反对2013年美国医学遗传学与基因组学学会（ACMG）指南的论据的批判性分析
Clin Genet. 2015 Apr;87(4):301-10. doi: 10.1111/cge.12460. Epub 2014 Oct 7.
引用本文的文献
1
Navigating Genetic Testing in Nephrology: Options and Decision-Making Strategies.肾内科中的基因检测导航：选择与决策策略
Kidney Int Rep. 2024 Dec 27;10(3):673-695. doi: 10.1016/j.ekir.2024.12.020. eCollection 2025 Mar.
2
Analogies in Genomics Policymaking: Debates and Drawbacks.基因组学政策制定中的类比：争议与缺陷。
Am J Hum Genet. 2020 Nov 5;107(5):797-801. doi: 10.1016/j.ajhg.2020.08.024.
3
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced Cancers.晚期癌症患者中肿瘤基因组分析产生的二级胚系发现的决策偏好
JCO Precis Oncol. 2017;1. doi: 10.1200/PO.17.00182. Epub 2017 Dec 21.
4
Genomic Contextualism: Shifting the Rhetoric of Genetic Exceptionalism.基因组语境主义：转变遗传例外主义的修辞。
Am J Bioeth. 2019 Jan;19(1):51-63. doi: 10.1080/15265161.2018.1544304.
5
Reconciling Opportunistic and Population Screening in Clinical Genomics.在临床基因组学中协调机会性筛查和人群筛查。
Mayo Clin Proc. 2019 Jan;94(1):103-109. doi: 10.1016/j.mayocp.2018.08.028.
6
Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study.接受基因组研究二次结果的影响：一项为期12个月的纵向研究。
J Genet Couns. 2018 Jun;27(3):709-722. doi: 10.1007/s10897-017-0172-x. Epub 2017 Nov 22.
7
When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.当分类模糊时：患者对临床全基因组测序结果类别的看法。
AJOB Empir Bioeth. 2017 Apr-Jun;8(2):82-88. doi: 10.1080/23294515.2017.1287786. Epub 2017 Jan 27.
8
Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).临床基因组测序与人群对“偶然”发现信息的偏好——从医学可操作基因（MAGs）到患者可操作基因（PAGs）。
PLoS One. 2017 Jul 3;12(7):e0179935. doi: 10.1371/journal.pone.0179935. eCollection 2017.
9
Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators.下一代核苷酸测序研究的知情同意：促进参与者与研究者之间的沟通
J Clin Transl Sci. 2017 Apr;1(2):115-120. doi: 10.1017/cts.2016.21. Epub 2017 Feb 7.
10
Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.晚期癌症患者对肿瘤基因组分析中二级胚系发现的兴趣和态度
J Oncol Pract. 2017 Jul;13(7):e590-e601. doi: 10.1200/JOP.2016.020057. Epub 2017 Jun 19.
本文引用的文献
1
Incidental findings in clinical genomics: a clarification.临床基因组学中的偶然发现：一项澄清
Genet Med. 2013 Aug;15(8):664-6. doi: 10.1038/gim.2013.82. Epub 2013 Jul 4.
2
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
3
Point-counterpoint. Ethics and genomic incidental findings.针锋相对。伦理学与基因组偶然发现
Science. 2013 May 31;340(6136):1047-8. doi: 10.1126/science.1240156. Epub 2013 May 16.
4
Incidental copy-number variants identified by routine genome testing in a clinical population.在临床人群中通过常规基因组检测鉴定的偶然拷贝数变异。
Genet Med. 2013 Jan;15(1):45-54. doi: 10.1038/gim.2012.95. Epub 2012 Aug 9.
5
Human genome sequencing in health and disease.人类基因组测序在健康与疾病中的应用。
Annu Rev Med. 2012;63:35-61. doi: 10.1146/annurev-med-051010-162644.
Zotero 插件